Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Shailly Gupta @MSF hopes to prevent Gilead from getting unmerited patent rights on the combination of #sofosbuvir and velpatasvir: Yuanqiong Hu @MSF_access 04:41 - 19 Dec 2017